NIFTY 50▼24,820.15
-194.45 (-0.78%)
SENSEX▼81,156.70
-531.75 (-0.65%)
NIFTY BANK▼50,762.00
-700.05 (-1.36%)
TATA MOTORS▼927.10
-3.65 (-0.39%)
SUZLON ENERGY▼70.93
-3.74 (-5.01%)
TATA STEEL▼164.06
-2.69 (-1.61%)
INDIAN RAILWAY FINANCE CORP▼145.25
-6.82 (-4.48%)
TATA POWER▼443.40
-23.25 (-4.98%)
RAIL VIKAS NIGAM▼457.40
-36.00 (-7.30%)
VODAFONE IDEA▼9.26
-0.53 (-5.41%)
RELIANCE INDUSTRIES▼2,739.30
-33.75 (-1.22%)
INDIAN RENEWABLE ENERGY▼212.55
-9.11 (-4.11%)
ZOMATO▼264.10
-11.20 (-4.07%)
RELIANCE POWER▼48.40
-2.55 (-5.00%)
ADANI POWER▼621.85
-20.25 (-3.15%)
YES BANK▼21.07
-0.88 (-4.01%)
STATE BANK OF INDIA▼777.10
-19.55 (-2.45%)
NHPC▼90.26
-2.91 (-3.12%)
HDFC BANK▼1,632.30
-25.35 (-1.53%)
JIO FIN SERVICES LTD▼335.20
-3.60 (-1.06%)
OLA ELECTRIC MOBILITY LTD▼90.93
-8.12 (-8.20%)
BHARAT ELECTRONICS▼267.80
-9.40 (-3.39%)
INDIAN OIL CORP▼163.29
-5.36 (-3.18%)
ADANI PORT & SEZ▼1,358.20
-55.50 (-3.93%)
GTL INFRA▼2.21
-0.10 (-4.33%)
MRF▼1,31,360.00
-2048.75 (-1.54%)
JAIPRAKASH POWER VENTURES▼18.45
-0.98 (-5.04%)
INDIAN RAILWAY TOURISM CORP▼856.60
-16.15 (-1.85%)
Suven Pharmaceuticals Share Price
SUVENPHAR
₹1,151.80-₹48.05 (-4%) TodayLast updated on 07 Oct, 2024 | 14:10 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹1,186.00 | Close₹1,199.85 |
Circuit range₹1,439.80 - ₹959.90 | Day range₹1,140.10 - ₹1,203.00 | Year range₹541.00 - ₹1,287.90 |
Volume3,00,150 | Avg. traded₹1,158.00 | Revenue (12m)₹934 Crs |
Suven PharmaceuticalsSuven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Manufacturing segment. Its geographical segments include India, the United States, Europe, and Rest of the world. In India, the Company sells bulk drugs and intermediates, fine chemicals & services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s subsidiaries are Suven Pharma Inc. and Casper Pharma Private Limited.
Suven Pharmaceuticals Key indicators
52 week high₹1,287.90 | 52 week low₹541.00 | P/E ratio126.89 |
P/B ratio14.47 | ROE16.03% | ROCE21.27% |
Dividend yield-- | Debt/Equity ratio0.02 | EPS11.97 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin45.37% | Net profit margin29.74% |
ROE16.03% | ROA13.73% |
ROCE21.27% |
Learn more
Suven Pharmaceuticals Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Oct 4 2024 | ₹1,190.30 | ₹1,199.85 | |
Thu, Oct 3 2024 | ₹1,196.00 | ₹1,194.25 | -0.70% |
Tue, Oct 1 2024 | ₹1,181.00 | ₹1,202.65 | |
Mon, Sep 30 2024 | ₹1,164.65 | ₹1,173.00 | |
Fri, Sep 27 2024 | ₹1,180.00 | ₹1,158.85 | -1.70% |
Thu, Sep 26 2024 | ₹1,195.25 | ₹1,178.85 | -1.55% |
Wed, Sep 25 2024 | ₹1,186.30 | ₹1,197.40 | |
Tue, Sep 24 2024 | ₹1,259.90 | ₹1,186.10 | -5.05% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 09 Sep 2022
Dividend • ₹5/share
Ex date 09 Sep 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 15 Feb 2022
Dividend • ₹2/share
Ex date 15 Feb 2022
Learn more